6 insiders reported 23 Form 4 transactions for REVELATION BIOSCIENCES, INC. (REVB) over the past 18 months (most recent 2026-05-01). Recent activity: Rolke James (Chief Executive Officer) Sell 10,115 shares, Zygmont Chester Stanley III (Chief Financial Officer) Sell 13,285 shares, Zygmont Chester Stanley III (Chief Financial Officer) Sell 13,100 shares, ROPER JESS (Director) Sell 1,591 shares, Chawla Lakhmir S (Director) Sell 2,261 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-01 | Rolke James | Chief Executive Officer | Sell | 10,115 | $11,430 |
| 2026-05-01 | Zygmont Chester Stanley III | Chief Financial Officer | Sell | 13,285 | $14,614 |
| 2026-02-05 | Zygmont Chester Stanley III | Chief Financial Officer | Sell | 13,100 | $21,615 |
| 2026-02-05 | ROPER JESS | Director | Sell | 1,591 | $2,943 |
| 2026-02-05 | Chawla Lakhmir S | Director | Sell | 2,261 | $4,183 |
| 2026-02-05 | CARVER JENNIFER | Director | Sell | 1,661 | $3,106 |
| 2026-02-05 | Rolke James | Chief Executive Officer | Sell | 8,521 | $15,849 |
| 2026-01-12 | Zygmont Chester Stanley III | Chief Financial Officer | Buy | 78,145 | $70,330 |
| 2026-01-12 | Rolke James | Chief Executive Officer | Buy | 532,829 | $479,546 |
| 2026-01-12 | Chawla Lakhmir S | Director | Buy | 41,981 | $37,783 |
| 2026-01-12 | CARVER JENNIFER | Director | Buy | 41,981 | $37,783 |
| 2026-01-12 | ROPER JESS | Director | Buy | 41,981 | $37,783 |
| 2025-10-31 | Chawla Lakhmir S | Director | Buy | 15,625 | $20,000 |
| 2025-10-31 | CARVER JENNIFER | Director | Buy | 15,625 | $20,000 |
| 2025-10-31 | Zygmont Chester Stanley III | Chief Financial Officer | Buy | 390,614 | $499,986 |
| 2025-10-31 | ROPER JESS | Director | Buy | 15,625 | $20,000 |
| 2025-10-31 | Rolke James | Chief Executive Officer | Buy | 390,614 | $499,986 |
| 2025-02-13 | CARVER JENNIFER | Director | Buy | 181 | $700 |
| 2025-02-13 | Rolke James | Chief Executive Officer | Buy | 30,095 | $116,468 |
| 2025-02-13 | Zygmont Chester Stanley III | Chief Financial Officer | Buy | 15,048 | $58,236 |
| 2025-02-13 | Chawla Lakhmir S | Director | Buy | 181 | $700 |
| 2025-02-13 | ROPER JESS | Director | Buy | 181 | $700 |
| 2025-02-13 | TIDMARSH GEORGE F | Director | Buy | 181 | $700 |
Source: SEC Form 4 filings · as of 2026-05-01